Quarterly Result29 Jan 2026, 01:10 pm
Eiko Lifesciences Approves Unaudited Financial Results for Quarter and Nine Months Ended 31 December 2025
AI Summary
Eiko Lifesciences Ltd, a company based in Thane, MH, has approved the unaudited financial results for the quarter and nine months ended 31 December 2025. The results were prepared in accordance with Indian Accounting Standard 34 and other accounting principles generally accepted in India. The company's revenue from operations for the nine months ended 31 December 2025 was INR 2,789.82 lakhs, compared to INR 2,589.79 lakhs for the same period in the previous year. The results were reviewed by the Audit Committee and approved by the Board of Directors on 29 January 2026.
Key Highlights
- Eiko Lifesciences approved unaudited financial results for the quarter and nine months ended 31 December 2025.
- Revenue from operations for the nine months ended 31 December 2025 was INR 2,789.82 lakhs.
- Results were prepared in accordance with Indian Accounting Standard 34 and other accounting principles generally accepted in India.
- Results reviewed by the Audit Committee and approved by the Board of Directors on 29 January 2026.
Price Impact
More from EIKO